Literature DB >> 2653093

Endotoxins and anti-endotoxins (their relevance to the anaesthetist and the intensive care specialist).

J G Brock-Utne1, S L Gaffin.   

Abstract

Endotoxins (lipopolysaccharides, LPS) are potent bacterial poisons always present within the intestines in considerable amounts. Several pathophysiological conditions such as hypovolaemia, hypoxia, intestinal ischaemia, burns and radiation lead to a breakdown in the barrier and depending upon the extent of the injury, endotoxins enter the systemic circulation in increasing amounts. Antibiotics do not inactivate the endotoxins which continue to exert their toxic effects leading to nausea, vomiting, diarrhoea, fever, disseminated intravascular coagulation, vascular collapse and organ failure. When nonabsorbable antibiotics are given prior to the insult, systemic endotoxaemia is prevented. Immunotherapy, using anti-lipopolysaccharide IgG, inactivates plasma endotoxins, destroys gram-negative bacteria and opsonises them and may become a major form of therapy. An outline of endotoxin and anti-lipopolysaccharide and its importance to the anaesthetist and intensive care specialist is presented.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653093     DOI: 10.1177/0310057X8901700111

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  3 in total

1.  Colitis and colonic mucosal barrier dysfunction.

Authors:  K R Gardiner; N H Anderson; B J Rowlands; A Barbul
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

2.  Comment on Hurley, J.C. Towards clinical application of anti-endotoxin antibodies; a re-appraisal of the disconnect. Toxins 2013, 5, 2589-2620.

Authors:  John G Brock-Utne
Journal:  Toxins (Basel)       Date:  2014-04-11       Impact factor: 4.546

3.  Thermoregulatory correlates of nausea in rats and musk shrews.

Authors:  Sukonthar Ngampramuan; Matteo Cerri; Flavia Del Vecchio; Joshua J Corrigan; Amornrat Kamphee; Alexander S Dragic; John A Rudd; Andrej A Romanovsky; Eugene Nalivaiko
Journal:  Oncotarget       Date:  2014-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.